FDA — authorised 18 June 1959
- Application: NDA011839
- Marketing authorisation holder: PFIZER
- Local brand name: PROVERA
- Indication: TABLET — ORAL
- Status: approved
FDA authorised Provera (medroxyprogesterone) on 18 June 1959
Yes. FDA authorised it on 18 June 1959.
PFIZER holds the US marketing authorisation.